Pub Date : 2024-09-29eCollection Date: 2024-07-01DOI: 10.47487/apcyccv.v5i3.402
Alejandro Narváez Orozco, Alberto Navarro Navajas, Carolina Cardona Buitrago, Emilio Herrera Céspedes, Juan Camilo Ortiz Uribe, Juan Andrés Delgado Restrepo, Juan Manuel Senior Sánchez, Jairo Alfonso Gándara Ricardo, Edison Muñoz Ortiz
Objetive: Congenital heart diseases (CHD) can be found in pregnant women. Although cardiac interventions in the catheterization laboratory are considered safe and effective, it is preferable to wait 3-6 months after delivery to correct simple, uncomplicated CHD; however, this may result in follow-up losses. The objective is to present our experience in correcting CHD during the early puerperium (EP).
Materials and methods: All cases of pregnant women with CHD, including atrial septal defect (ASD), patent ductus arteriosus (PDA), and aortic coarctation (CoA) between 2017-2023, who underwent percutaneous defect correction during the EP were collected.
Results: Fifteen pregnant women were included, diagnosed with ASD (5), PDA (6), and CoA (4). Five patients (33.3%) were classified as WHO risk class IV; the procedure was successful in 80% of the cases, and only 1 patient presented complications.
Conclusions: In our experience, the closure of uncomplicated congenital defects during the EP did not present major complications and could be a treatment strategy to prevent follow-up losses after delivery in pregnant women with CHD.
目标孕妇可能患有先天性心脏病(CHD)。尽管在导管室进行心脏介入治疗被认为是安全有效的,但最好在分娩后 3-6 个月再进行简单、无并发症的先天性心脏病矫治;然而,这可能会导致随访损失。本文旨在介绍我们在产后早期(EP)矫正先天性心脏病的经验:收集2017-2023年间所有在产褥期接受经皮缺损矫治的CHD孕妇病例,包括房间隔缺损(ASD)、动脉导管未闭(PDA)和主动脉瓣狭窄(CoA):共纳入15名孕妇,诊断为ASD(5名)、PDA(6名)和CoA(4名)。5名患者(33.3%)被列为WHO IV级风险;80%的病例手术成功,只有1名患者出现并发症:根据我们的经验,在 EP 期间闭合无并发症的先天性缺陷不会出现重大并发症,可以作为一种治疗策略,防止患有先天性心脏病的孕妇在分娩后出现随访损失。
{"title":"[Percutaneous correction of structural congenital heart diseases during the early puerperium. Experience of a center].","authors":"Alejandro Narváez Orozco, Alberto Navarro Navajas, Carolina Cardona Buitrago, Emilio Herrera Céspedes, Juan Camilo Ortiz Uribe, Juan Andrés Delgado Restrepo, Juan Manuel Senior Sánchez, Jairo Alfonso Gándara Ricardo, Edison Muñoz Ortiz","doi":"10.47487/apcyccv.v5i3.402","DOIUrl":"https://doi.org/10.47487/apcyccv.v5i3.402","url":null,"abstract":"<p><strong>Objetive: </strong>Congenital heart diseases (CHD) can be found in pregnant women. Although cardiac interventions in the catheterization laboratory are considered safe and effective, it is preferable to wait 3-6 months after delivery to correct simple, uncomplicated CHD; however, this may result in follow-up losses. The objective is to present our experience in correcting CHD during the early puerperium (EP).</p><p><strong>Materials and methods: </strong>All cases of pregnant women with CHD, including atrial septal defect (ASD), patent ductus arteriosus (PDA), and aortic coarctation (CoA) between 2017-2023, who underwent percutaneous defect correction during the EP were collected.</p><p><strong>Results: </strong>Fifteen pregnant women were included, diagnosed with ASD (5), PDA (6), and CoA (4). Five patients (33.3%) were classified as WHO risk class IV; the procedure was successful in 80% of the cases, and only 1 patient presented complications.</p><p><strong>Conclusions: </strong>In our experience, the closure of uncomplicated congenital defects during the EP did not present major complications and could be a treatment strategy to prevent follow-up losses after delivery in pregnant women with CHD.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"5 3","pages":"137-142"},"PeriodicalIF":0.0,"publicationDate":"2024-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11473075/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142482118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-29eCollection Date: 2024-07-01DOI: 10.47487/apcyccv.v5i3.366
Katia Bravo-Jaimes, Daniel Lozano Moreno, Jeannette Orozco, William Rosales, Nely Macedo, Mónica Medina, Gian Huamán, Rafael Márquez, Miriam Valdez, Ana Lucía Vásquez Choy, Henry A Zapata, Julio Sánchez Tonohuye, Carmen Dávila Aliaga
Congenital heart diseases are the most common congenital malformations worldwide and represent one of the leading causes of neonatal death, in addition to the significant use of human and financial resources by health systems. The purpose of this document is to support the implementation of neonatal screening for critical congenital heart diseases using pulse oximetry according to the different geographical altitudes of Peru. This technology is widely used worldwide and has high sensitivity, specificity, and cost-effectiveness. At many latitudes, it has led to better survival in this group of patients and in the neonatal population in general since its use in the early detection of sepsis, pneumonia, and other conditions that affect the oxygenation of the newborn. Neonatal screening for critical congenital heart disease is applicable at all levels of healthcare at a national level, and its implementation must be a priority to improve neonatal health.
{"title":"[Neonatal screening for critical congenital heart diseases in Peru: an urgent call].","authors":"Katia Bravo-Jaimes, Daniel Lozano Moreno, Jeannette Orozco, William Rosales, Nely Macedo, Mónica Medina, Gian Huamán, Rafael Márquez, Miriam Valdez, Ana Lucía Vásquez Choy, Henry A Zapata, Julio Sánchez Tonohuye, Carmen Dávila Aliaga","doi":"10.47487/apcyccv.v5i3.366","DOIUrl":"https://doi.org/10.47487/apcyccv.v5i3.366","url":null,"abstract":"<p><p>Congenital heart diseases are the most common congenital malformations worldwide and represent one of the leading causes of neonatal death, in addition to the significant use of human and financial resources by health systems. The purpose of this document is to support the implementation of neonatal screening for critical congenital heart diseases using pulse oximetry according to the different geographical altitudes of Peru. This technology is widely used worldwide and has high sensitivity, specificity, and cost-effectiveness. At many latitudes, it has led to better survival in this group of patients and in the neonatal population in general since its use in the early detection of sepsis, pneumonia, and other conditions that affect the oxygenation of the newborn. Neonatal screening for critical congenital heart disease is applicable at all levels of healthcare at a national level, and its implementation must be a priority to improve neonatal health.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"5 3","pages":"157-166"},"PeriodicalIF":0.0,"publicationDate":"2024-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11473077/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142482117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-29eCollection Date: 2024-07-01DOI: 10.47487/apcyccv.v5i3.410
Kevin Velarde-Acosta, Josh Yefry Moscoso Ramirez, Paol Rojas, Lucy Susanibar, Lady Diana Quintana Reusche, Angela Cachicatari, Roberto Baltodano-Arellano
Shaggy aorta (SA) is characterized by a critical and extensive atheromatous disease of the thoracic and abdominal aorta. This degenerative and dangerous pathology is the result of the confluence of multiple modifiable and non-modifiable risk factors. The clinical importance of this pathology relies on the various syndromes that can develop from its etiopathogenesis, which generates great morbidity and mortality in the affected patients. In this document, we present an updated and detailed review of this entity, developing aspects of its pathophysiology, diagnosis, including the importance of multimodal imaging, and its therapeutic approach. Finally, we present the clinical settings of patients with SA in different aortic scenarios (aortic dissection, ulcerated plaques, and thrombosed aneurysms) that denote the nature of this disease and its high mortality.
主动脉畸形(SA)的特征是胸腹主动脉发生严重而广泛的粥样病变。这种退行性危险病变是多种可改变和不可改变的危险因素共同作用的结果。这种病症的临床重要性在于其病因机制可能导致的各种综合征,从而给患者带来极大的发病率和死亡率。在本文件中,我们将对这一病症进行最新的详细综述,从病理生理学、诊断(包括多模态成像的重要性)和治疗方法等方面进行阐述。最后,我们介绍了 SA 患者在不同主动脉情况(主动脉夹层、溃疡斑块和血栓性动脉瘤)下的临床表现,从而说明了这种疾病的性质及其高死亡率。
{"title":"Shaggy aorta: ideal substrate for disaster. Updated review.","authors":"Kevin Velarde-Acosta, Josh Yefry Moscoso Ramirez, Paol Rojas, Lucy Susanibar, Lady Diana Quintana Reusche, Angela Cachicatari, Roberto Baltodano-Arellano","doi":"10.47487/apcyccv.v5i3.410","DOIUrl":"https://doi.org/10.47487/apcyccv.v5i3.410","url":null,"abstract":"<p><p>Shaggy aorta (SA) is characterized by a critical and extensive atheromatous disease of the thoracic and abdominal aorta. This degenerative and dangerous pathology is the result of the confluence of multiple modifiable and non-modifiable risk factors. The clinical importance of this pathology relies on the various syndromes that can develop from its etiopathogenesis, which generates great morbidity and mortality in the affected patients. In this document, we present an updated and detailed review of this entity, developing aspects of its pathophysiology, diagnosis, including the importance of multimodal imaging, and its therapeutic approach. Finally, we present the clinical settings of patients with SA in different aortic scenarios (aortic dissection, ulcerated plaques, and thrombosed aneurysms) that denote the nature of this disease and its high mortality.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"5 3","pages":"143-152"},"PeriodicalIF":0.0,"publicationDate":"2024-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11473078/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142482120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-29eCollection Date: 2024-07-01DOI: 10.47487/apcyccv.v5i3.394
Alex Catalán Cabrera, Karen Condori Alvino, Mónica Medina Durand, Ricardo Galvez-Arévalo
Objective: Balloon atrioseptostomy is an emergency procedure in congenital heart diseases requiring an atrial septal defect to increase cardiac output in right-sided obstructive lesions or to improve mixing in patients with transposition of the great arteries. This procedure is currently performed with both fluoroscopy and echocardiography. The main objective is to describe our experience with the use of balloon atrioseptostomy under echocardiographic and fluoroscopic guidance in patients under 3 months.
Materials and methods: A descriptive, comparative and retrospective study in patients in whom balloon atrioseptostomy was performed under echocardiographic and fluoroscopic guidance between 2018 and 2023 in a referral hospital in Peru.
Results: 36 patients were analyzed, of which 21 were from the fluoroscopy group. and 15 patients from the echocardiography group. More than 2/3 of the cases were males, and more than 60% of patients in both groups had transposition of the great vessels. No significant differences were found in terms of ventilatory support and inotropic support. The success of the procedure was 100% in both groups, without complications.
Conclusion: Both balloon atrioseptostomy performed by fluoroscopy and those performed by echocardiography were successful and without complications, emphasizing that the one performed by echocardiography is performed in the patient's crib, avoiding the transfer of the critical unit to the angiography room and without the use of radiation.
{"title":"[Balloon atrioseptostomy under echocardiographic and fluoroscopic guide in patients with congenital heart diseases under 3 months in a national reference pediatric center].","authors":"Alex Catalán Cabrera, Karen Condori Alvino, Mónica Medina Durand, Ricardo Galvez-Arévalo","doi":"10.47487/apcyccv.v5i3.394","DOIUrl":"https://doi.org/10.47487/apcyccv.v5i3.394","url":null,"abstract":"<p><strong>Objective: </strong>Balloon atrioseptostomy is an emergency procedure in congenital heart diseases requiring an atrial septal defect to increase cardiac output in right-sided obstructive lesions or to improve mixing in patients with transposition of the great arteries. This procedure is currently performed with both fluoroscopy and echocardiography. The main objective is to describe our experience with the use of balloon atrioseptostomy under echocardiographic and fluoroscopic guidance in patients under 3 months.</p><p><strong>Materials and methods: </strong>A descriptive, comparative and retrospective study in patients in whom balloon atrioseptostomy was performed under echocardiographic and fluoroscopic guidance between 2018 and 2023 in a referral hospital in Peru.</p><p><strong>Results: </strong>36 patients were analyzed, of which 21 were from the fluoroscopy group. and 15 patients from the echocardiography group. More than 2/3 of the cases were males, and more than 60% of patients in both groups had transposition of the great vessels. No significant differences were found in terms of ventilatory support and inotropic support. The success of the procedure was 100% in both groups, without complications.</p><p><strong>Conclusion: </strong>Both balloon atrioseptostomy performed by fluoroscopy and those performed by echocardiography were successful and without complications, emphasizing that the one performed by echocardiography is performed in the patient's crib, avoiding the transfer of the critical unit to the angiography room and without the use of radiation.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"5 3","pages":"132-136"},"PeriodicalIF":0.0,"publicationDate":"2024-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11473072/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142482114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-29eCollection Date: 2024-07-01DOI: 10.47487/apcyccv.v5i3.413
Marco Antonio Ponce-Gallegos, Miguel Mendoza-Mujica, Jaime Ponce-Gallegos, Jesús Alberto García-Diaz, Jorge Armando Zelada-Pineda, Diego Araiza-Garaygordobil
Lung ultrasound is a tool that is increasingly gaining strength in the initial evaluation of the patient in the emergency department and in critical care areas, making it particularly useful for cardiologists. In patients with ST elevation and acute myocardial infarction it has been observed that 25-45% of patients are wrongly classified as Class I in the Killip and Kimball classification after lung ultrasound (subclinical congestion). The clinical relevance of this finding lies in the fact that the greater the number of B lines, the greater short- and long-term the mortality is. An important advantage is that no prolonged time for learning the technique is required. More studies are needed to evaluate the role and importance of subclinical congestion in patients with acute myocardial infarction. Unfortunately, ultrasound is not widely available in developing countries, so the physical examination will continue to play an important role in the initial evaluation of patients with acute myocardial infraction.
在急诊科和重症监护领域,肺部超声是一种对患者进行初步评估的工具,其作用日益增强,对心脏病专家尤其有用。据观察,在 ST 波抬高和急性心肌梗死患者中,有 25%-45% 的患者在肺部超声检查后被错误地划分为 Killip 和 Kimball 分级中的 I 级(亚临床充血)。这一发现的临床意义在于,B 线数量越多,短期和长期死亡率越高。该技术的一个重要优点是无需长时间学习。需要更多的研究来评估亚临床充血在急性心肌梗死患者中的作用和重要性。遗憾的是,超声波在发展中国家并不普及,因此体格检查在急性心肌梗死患者的初步评估中仍将发挥重要作用。
{"title":"Killip and Kimball classification in the Ultrasound era: Is it time to redefine?","authors":"Marco Antonio Ponce-Gallegos, Miguel Mendoza-Mujica, Jaime Ponce-Gallegos, Jesús Alberto García-Diaz, Jorge Armando Zelada-Pineda, Diego Araiza-Garaygordobil","doi":"10.47487/apcyccv.v5i3.413","DOIUrl":"https://doi.org/10.47487/apcyccv.v5i3.413","url":null,"abstract":"<p><p>Lung ultrasound is a tool that is increasingly gaining strength in the initial evaluation of the patient in the emergency department and in critical care areas, making it particularly useful for cardiologists. In patients with ST elevation and acute myocardial infarction it has been observed that 25-45% of patients are wrongly classified as Class I in the Killip and Kimball classification after lung ultrasound (subclinical congestion). The clinical relevance of this finding lies in the fact that the greater the number of B lines, the greater short- and long-term the mortality is. An important advantage is that no prolonged time for learning the technique is required. More studies are needed to evaluate the role and importance of subclinical congestion in patients with acute myocardial infarction. Unfortunately, ultrasound is not widely available in developing countries, so the physical examination will continue to play an important role in the initial evaluation of patients with acute myocardial infraction.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"5 3","pages":"153-156"},"PeriodicalIF":0.0,"publicationDate":"2024-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11473071/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142482119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-24eCollection Date: 2024-04-01DOI: 10.47487/apcyccv.v5i2.363
Rodrigo Chavez-Ecos, Kiara Camacho-Caballero, Marcelo S Chavez-Ecos, Miguel A Chavez-Gutarra, Oscar Aguirre-Zurita, Fabian A Chavez-Ecos
{"title":"[Analysis of the quality of an artificial intelligence mobile application for ECG interpretation].","authors":"Rodrigo Chavez-Ecos, Kiara Camacho-Caballero, Marcelo S Chavez-Ecos, Miguel A Chavez-Gutarra, Oscar Aguirre-Zurita, Fabian A Chavez-Ecos","doi":"10.47487/apcyccv.v5i2.363","DOIUrl":"10.47487/apcyccv.v5i2.363","url":null,"abstract":"","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"5 2","pages":"e363"},"PeriodicalIF":0.0,"publicationDate":"2024-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11247966/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141629401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-24eCollection Date: 2024-04-01DOI: 10.47487/apcyccv.v5i2.368.
L Marco Lopez-Rojas, Cynthia Paola Paredes Paucar, Paol Rojas De La Cuba, W Germán Yábar Galindo, Jorge Orlando Martos Salcedo, Piero Custodio-Sánchez
{"title":"[Reply yo the letter to the editor : \"Keeping an eye on the pharmacoinvasive strategy\"].","authors":"L Marco Lopez-Rojas, Cynthia Paola Paredes Paucar, Paol Rojas De La Cuba, W Germán Yábar Galindo, Jorge Orlando Martos Salcedo, Piero Custodio-Sánchez","doi":"10.47487/apcyccv.v5i2.368.","DOIUrl":"10.47487/apcyccv.v5i2.368.","url":null,"abstract":"","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"5 2","pages":"e368"},"PeriodicalIF":0.0,"publicationDate":"2024-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11247967/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141629403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-24eCollection Date: 2024-04-01DOI: 10.47487/apcyccv.v5i2.342
Alejandro Alcaraz-Guzmán, Eder Jonathan Amaro-Palomo, Arturo Maximiliano Ruiz-Beltrán, Braiana Ángeles Díaz-Herrera, Raúl Rodrigo Neri-Bale, Lilia Hernández-Bravo, Manuel A Candia-Ramírez, Rodrigo Gopar-Nieto, Héctor González-Pacheco, Jorge Daniel Sierra-Lara Martinez, Alexandra Arias-Mendoza, Diego Araiza-Garaygordobil
Objective: . Acute myocardial infarction-related cardiogenic shock (AMI-CS) is often accompanied by tachycardia, which, in turn, increases myocardial oxygen consumption and hinders the use of ventricular assist devices, such as intra-aortic balloon pump. Evidence suggests that ivabradine may reduce heart rate (HR) without affecting other hemodynamic parameters. The aim of the present study was to determine the effect of ivabradine on reducing HR and changes in other hemodynamic parameters such as cardiac index (CI), in patients with AMI-CS and tachycardia.
Materials and methods: . A single-center, open label, randomized clinical trial included patients diagnosed with AMI-CS and tachycardia with >100 beats per minute (BPM). Heart rate, cardiac index, and other hemodynamic parameters measured by pulmonary flotation catheter were compared at 0, 6, 12, 24, and 48 hours after randomization.
Results: . A total of 12 patients were randomized; 6 received standard therapy, and 6 received ivabradine in addition to standard therapy. Baseline clinical characteristics were similar at randomization. A statistically significant lower heart rate was found at 12 hours (p=0.003) and 48 hours (p=0.029) after randomization, with differences of -23.3 (-8.2 to -38.4) BPM and -12.6 (-0.5 to -25.9) BPM, respectively. No differences in cardiac index, or any other evaluated hemodynamic parameters, length of hospital stay, nor mortality rate were noted between both groups.
Conclusions: . The use of ivabradine in patients with AMI-CS was associated with a significant reduction in heart rate at 12 and 48 h, without affecting other hemodynamic parameters.
{"title":"A randomized controlled trial of ivabradine in patients with acute myocardial infarction related cardiogenic shock.","authors":"Alejandro Alcaraz-Guzmán, Eder Jonathan Amaro-Palomo, Arturo Maximiliano Ruiz-Beltrán, Braiana Ángeles Díaz-Herrera, Raúl Rodrigo Neri-Bale, Lilia Hernández-Bravo, Manuel A Candia-Ramírez, Rodrigo Gopar-Nieto, Héctor González-Pacheco, Jorge Daniel Sierra-Lara Martinez, Alexandra Arias-Mendoza, Diego Araiza-Garaygordobil","doi":"10.47487/apcyccv.v5i2.342","DOIUrl":"10.47487/apcyccv.v5i2.342","url":null,"abstract":"<p><strong>Objective: </strong>. Acute myocardial infarction-related cardiogenic shock (AMI-CS) is often accompanied by tachycardia, which, in turn, increases myocardial oxygen consumption and hinders the use of ventricular assist devices, such as intra-aortic balloon pump. Evidence suggests that ivabradine may reduce heart rate (HR) without affecting other hemodynamic parameters. The aim of the present study was to determine the effect of ivabradine on reducing HR and changes in other hemodynamic parameters such as cardiac index (CI), in patients with AMI-CS and tachycardia.</p><p><strong>Materials and methods: </strong>. A single-center, open label, randomized clinical trial included patients diagnosed with AMI-CS and tachycardia with >100 beats per minute (BPM). Heart rate, cardiac index, and other hemodynamic parameters measured by pulmonary flotation catheter were compared at 0, 6, 12, 24, and 48 hours after randomization.</p><p><strong>Results: </strong>. A total of 12 patients were randomized; 6 received standard therapy, and 6 received ivabradine in addition to standard therapy. Baseline clinical characteristics were similar at randomization. A statistically significant lower heart rate was found at 12 hours (p=0.003) and 48 hours (p=0.029) after randomization, with differences of -23.3 (-8.2 to -38.4) BPM and -12.6 (-0.5 to -25.9) BPM, respectively. No differences in cardiac index, or any other evaluated hemodynamic parameters, length of hospital stay, nor mortality rate were noted between both groups.</p><p><strong>Conclusions: </strong>. The use of ivabradine in patients with AMI-CS was associated with a significant reduction in heart rate at 12 and 48 h, without affecting other hemodynamic parameters.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"5 2","pages":"e342"},"PeriodicalIF":0.0,"publicationDate":"2024-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11247970/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141629404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-24eCollection Date: 2024-04-01DOI: 10.47487/apcyccv.v5i2.362
José Martín Alanís-Naranjo, Kevin David Aragón-Ontiveros, Julio César Rivera-Hermosillo, Virginia Campos-Garcilazo
Bidirectional ventricular tachycardia (BVT) is a rare form of malignant ventricular arrhythmia characterized by beat-to-beat alternation in the QRS axis. BVT is a hallmark of digitalis toxicity, but digoxin-induced BVT secondary to digoxin-diuretic interaction in cardiac surgery patients is not widely reported. We present the case of a 62-year-old woman undergoing mitral valve replacement with tricuspid annuloplasty who developed postoperative congestive heart failure and vasoplegic syndrome requiring norepinephrine, vasopressin, and loop diuretics. During postoperative care, she presented atrial fibrillation with rapid ventricular response, achieving rate control with digoxin, but later displayed hemodynamically stable BVT associated with digitalis toxicity. The case highlights the importance of physicians monitoring digoxin toxicity when prescribing digoxin to patients with a diuretic regimen, particularly loop diuretics. During digoxin-induced-BVT, supportive treatment, including discontinuing digitalis coupled with potassium and magnesium supplements, can be considered as long as digoxin-specific antibodies are unavailable, and the patient is hemodynamically stable.
{"title":"Bidirectional ventricular tachycardia due to digoxin-diuretic interaction in post-cardiac surgery patient: a case report.","authors":"José Martín Alanís-Naranjo, Kevin David Aragón-Ontiveros, Julio César Rivera-Hermosillo, Virginia Campos-Garcilazo","doi":"10.47487/apcyccv.v5i2.362","DOIUrl":"10.47487/apcyccv.v5i2.362","url":null,"abstract":"<p><p>Bidirectional ventricular tachycardia (BVT) is a rare form of malignant ventricular arrhythmia characterized by beat-to-beat alternation in the QRS axis. BVT is a hallmark of digitalis toxicity, but digoxin-induced BVT secondary to digoxin-diuretic interaction in cardiac surgery patients is not widely reported. We present the case of a 62-year-old woman undergoing mitral valve replacement with tricuspid annuloplasty who developed postoperative congestive heart failure and vasoplegic syndrome requiring norepinephrine, vasopressin, and loop diuretics. During postoperative care, she presented atrial fibrillation with rapid ventricular response, achieving rate control with digoxin, but later displayed hemodynamically stable BVT associated with digitalis toxicity. The case highlights the importance of physicians monitoring digoxin toxicity when prescribing digoxin to patients with a diuretic regimen, particularly loop diuretics. During digoxin-induced-BVT, supportive treatment, including discontinuing digitalis coupled with potassium and magnesium supplements, can be considered as long as digoxin-specific antibodies are unavailable, and the patient is hemodynamically stable.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"5 2","pages":"e362"},"PeriodicalIF":0.0,"publicationDate":"2024-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11247964/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141629406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-24eCollection Date: 2024-04-01DOI: 10.47487/apcyccv.v5i2.339
Lucrecia María Burgos, Franco Nicolás Ballari, Rocío Consuelo Baro Vila, María Antonella de Bortoli, Mariano Vrancic, Mirta Diez
Constrictive pericarditis (CP) is an infrequent complication following heart transplantation (HTx) and arises from diverse postoperative occurrences, including mediastinitis, pericardial effusion, or allograft rejection. Indeed, this rare clinical entity can be misdiagnosed as a rejection episode or restrictive cardiomyopathy. In this report, we present the case of a 43-year-old male who underwent HTx 1.5 years prior and was subsequently admitted to our center due to the gradual onset of symptoms indicative of right congestive heart failure, with an initial diagnosis of constrictive pericarditis.
{"title":"Acute graft rejection mimicking constrictive pericarditis after heart transplantation. A case report.","authors":"Lucrecia María Burgos, Franco Nicolás Ballari, Rocío Consuelo Baro Vila, María Antonella de Bortoli, Mariano Vrancic, Mirta Diez","doi":"10.47487/apcyccv.v5i2.339","DOIUrl":"10.47487/apcyccv.v5i2.339","url":null,"abstract":"<p><p>Constrictive pericarditis (CP) is an infrequent complication following heart transplantation (HTx) and arises from diverse postoperative occurrences, including mediastinitis, pericardial effusion, or allograft rejection. Indeed, this rare clinical entity can be misdiagnosed as a rejection episode or restrictive cardiomyopathy. In this report, we present the case of a 43-year-old male who underwent HTx 1.5 years prior and was subsequently admitted to our center due to the gradual onset of symptoms indicative of right congestive heart failure, with an initial diagnosis of constrictive pericarditis.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"5 2","pages":"e399"},"PeriodicalIF":0.0,"publicationDate":"2024-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11247968/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141629405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}